These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14522356)

  • 1. [Volume-effect and radiotherapy [II]. Part II: volume-effect and normal tissue].
    Huchet A; Caudry M; Belkacémi Y; Trouette R; Vendrely V; Causse N; Récaldini L; Atlan D; Maire JP
    Cancer Radiother; 2003 Oct; 7(5):353-62. PubMed ID: 14522356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Volume-effect in radiation therapy part one: volume-effect and tumour].
    Huchet A; Caudry M; Belkacémi Y; Trouette R; Vendrely V; Causse N; Récaldini L; Dahan O; Wu J; Maire JP
    Cancer Radiother; 2003 Apr; 7(2):79-89. PubMed ID: 12719037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Radiotherapy Induced Normal Tissue Complications: An Overview beyond Phenomenological Models.
    D'Andrea M; Benassi M; Strigari L
    Comput Math Methods Med; 2016; 2016():2796186. PubMed ID: 28044088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dosimetric factors predictive of late toxicity in prostate cancer radiotherapy].
    de Crevoisier R; Fiorino C; Dubray B
    Cancer Radiother; 2010 Oct; 14(6-7):460-8. PubMed ID: 20797890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A FORTRAN program for the optimization of radiotherapy treatment planning using the complication probability factor (CPF).
    Wolbarst AB; Sternick ES; Curran BH; Kosinski RJ; Dritschilo A
    Comput Programs Biomed; 1980 Apr; 11(2):99-104. PubMed ID: 7389321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Probabilities of controlling tumors and complications (TCP/NTCP) after radiotherapy: methodologic, physical, and biological aspects].
    Kulik C; Mazurier J; Lartigau E
    Cancer Radiother; 2002 Nov; 6 Suppl 1():155s-165s. PubMed ID: 12587394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test procedures for verification of an electron pencil beam algorithm implemented for treatment planning.
    Blomquist M; Karlsson M; Karlsson M
    Radiother Oncol; 1996 Jun; 39(3):271-86. PubMed ID: 8783404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in radiotherapy.
    Svensson H; Möller TR;
    Acta Oncol; 2003; 42(5-6):430-42. PubMed ID: 14596505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of radiation-induced normal tissue complications in radiotherapy using functional image data.
    Nioutsikou E; Partridge M; Bedford JL; Webb S
    Phys Med Biol; 2005 Mar; 50(6):1035-46. PubMed ID: 15798307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of equivalent uniform doses and the volume parameter.
    Kvinnsland Y; Muren LP; Dahl O
    Phys Med Biol; 2004 Aug; 49(15):3341-52. PubMed ID: 15379017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confidence intervals in dose volume histogram computation.
    Cutanda Henríquez F; Vargas Castrillón S
    Med Phys; 2010 Apr; 37(4):1545-53. PubMed ID: 20443475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting dose-volume histograms for organs-at-risk in IMRT planning.
    Appenzoller LM; Michalski JM; Thorstad WL; Mutic S; Moore KL
    Med Phys; 2012 Dec; 39(12):7446-61. PubMed ID: 23231294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontumor integral dose variation in conventional radiotherapy treatment planning.
    D'Souza WD; Rosen II
    Med Phys; 2003 Aug; 30(8):2065-71. PubMed ID: 12945972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of radiological models and radiological invariants (constants). Part 1].
    Klepper L Ia
    Med Tekh; 2005; (3):27-32. PubMed ID: 16106957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An aggregation method for determination of parameters of mathematical models].
    Klepper LIa
    Med Tekh; 2008; (1):33-7. PubMed ID: 18354909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Model of biological equivalent dose distribution modified by volume effect in radiotherapy].
    Oouchi A; Nagakura H; Sakata K; Hareyama M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Mar; 61(4):163-8. PubMed ID: 11321816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
    Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
    Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.